Annual EBITDA
$2.16B$240.89M+12.53%
Summary
- Current Value
- As of today, RMD annual EBITDA is $2.16B, up +12.53% on
- Historical Performance
- RMD annual EBITDA is up +60.48% over the past 3 years, up +96.05% over the past 5 years
- All-Time High Comparison
- RMD annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- RMD annual EBITDA is +60.48% above its 3-year low of $1.35B reached on an earlier date
- Sector Comparison
- RMD annual EBITDA is higher than 95.39% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $2.16B | +12.5% | +60.5% | +96.0% | +536.8% | |
| Quarterly EBITDA | $536.67M | +3.2% | +56.7% | +73.4% | +560.2% | |
| TTM EBITDA | $2.18B | +9.1% | +59.2% | +90.5% | +553.4% | |
| Price | $235.30 | -5.8% | +52.9% | -9.7% | +705.0% | |
| PE Ratio | 21.42 | -16.2% | -14.4% | -72.0% | +3.3% | |
| Annual Revenue | $5.65B | +9.8% | +33.9% | +76.8% | +354.8% | |
| Annual EPS | $10.43 | +9.7% | +71.3% | +221.9% | +624.3% | |
| $1.92B | +13.8% | +66.7% | +110.4% | +613.1% | ||
| Annual Net Income | $1.52B | +8.8% | +69.7% | +221.0% | +571.1% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.16B | at high | |
| 5Y | $2.16B | at high | |
| All | $2.16B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.35B | N/A | +60.5% |
| 5Y | $1.10B | N/A | +96.0% |
| All | $900.00K | >+9999.0% |
EBITDA History
FAQ
- What is the current annual EBITDA of RMD?
- As of today, RMD annual EBITDA is $2.16B
- What is 1-year change in RMD annual EBITDA?
- RMD annual EBITDA is up +12.53% year-over-year
- What is 3-year change in RMD annual EBITDA?
- RMD annual EBITDA is up +60.48% over the past 3 years
- How far is RMD annual EBITDA from its all-time high?
- RMD annual EBITDA is currently at its all-time high
- How does RMD annual EBITDA rank versus sector peers?
- RMD annual EBITDA is higher than 95.39% of companies in Healthcare sector
- When is RMD next annual earnings release?
- As of today, the next annual earnings release for RMD has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$536.67M$26.91M+5.28%
Summary
- Current Value
- As of today, RMD quarterly EBITDA is $536.67M, up +5.28% on
- Historical Performance
- RMD quarterly EBITDA is up +3.20% year-over-year, up +56.72% over the past 3 years
- All-Time High Comparison
- RMD quarterly EBITDA is currently -6.62% below its historical high of $574.74M set on
- 3-Year Low Comparison
- RMD quarterly EBITDA is +56.72% above its 3-year low of $342.44M reached on an earlier date
- Sector Comparison
- RMD quarterly EBITDA is higher than 94.87% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $536.67M | +5.3% | +3.2% | +56.7% | +73.4% | |
| Annual EBITDA | $2.16B | – | +12.5% | +60.5% | +96.0% | |
| TTM EBITDA | $2.18B | +0.8% | +9.1% | +59.2% | +90.5% | |
| Price | $235.30 | +5.4% | -5.8% | +52.9% | -9.7% | |
| PE Ratio | 21.42 | +0.1% | -16.2% | -14.4% | -72.0% | |
| Quarterly Revenue | $1.41B | -3.3% | +5.9% | +28.4% | +56.5% | |
| Quarterly EPS | $2.92 | +10.4% | +23.1% | +96.3% | +110.6% | |
| $484.84M | +6.6% | +4.9% | +67.8% | +85.1% | ||
| Quarterly Net Income | $418.41M | +9.1% | +20.1% | +90.7% | +105.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $574.74M | -6.6% | |
| 3Y | $574.74M | -6.6% | |
| 5Y | $574.74M | -6.6% | |
| All | $574.74M | -6.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $509.76M | +5.3% | |
| 3Y | $342.44M | N/A | +56.7% |
| 5Y | $285.87M | +87.7% | |
| All | -$14.00M | +3933.4% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of RMD?
- As of today, RMD quarterly EBITDA is $536.67M
- What is RMD quarterly EBITDA most recent change?
- RMD quarterly EBITDA was up +5.28% on September 30, 2026
- What is 1-year change in RMD quarterly EBITDA?
- RMD quarterly EBITDA is up +3.20% year-over-year
- How far is RMD quarterly EBITDA from its all-time high?
- RMD quarterly EBITDA is currently -6.62% below its historical high of $574.74M set on March 31, 2026
- How does RMD quarterly EBITDA rank versus sector peers?
- RMD quarterly EBITDA is higher than 94.87% of companies in Healthcare sector
- When is RMD next earnings release?
- The next earnings release for RMD is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$2.18B$16.65M+0.77%
Summary
- Current Value
- As of today, RMD TTM EBITDA is $2.18B, up +0.77% on
- Historical Performance
- RMD TTM EBITDA is up +9.07% year-over-year, up +59.23% over the past 3 years
- All-Time High Comparison
- RMD TTM EBITDA is currently -0.20% below its historical high of $2.19B set on
- 3-Year Low Comparison
- RMD TTM EBITDA is +59.23% above its 3-year low of $1.37B reached on an earlier date
- Sector Comparison
- RMD TTM EBITDA is higher than 95.16% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $2.18B | +0.8% | +9.1% | +59.2% | +90.5% | |
| Annual EBITDA | $2.16B | – | +12.5% | +60.5% | +96.0% | |
| Quarterly EBITDA | $536.67M | +5.3% | +3.2% | +56.7% | +73.4% | |
| Price | $235.30 | +5.4% | -5.8% | +52.9% | -9.7% | |
| PE Ratio | 21.42 | +0.1% | -16.2% | -14.4% | -72.0% | |
| TTM Revenue | $5.73B | +1.4% | +9.0% | +31.0% | +71.2% | |
| TTM EPS | $10.98 | +5.3% | +12.4% | +78.7% | +222.6% | |
| $1.95B | +1.2% | +10.4% | +67.1% | +103.2% | ||
| TTM Net Income | $1.59B | +4.6% | +10.8% | +75.8% | +218.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.19B | -0.2% | |
| 3Y | $2.19B | -0.2% | |
| 5Y | $2.19B | -0.2% | |
| All | $2.19B | -0.2% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.00B | N/A | +9.1% |
| 3Y | $1.37B | N/A | +59.2% |
| 5Y | $1.15B | N/A | +90.5% |
| All | $700.00K | >+9999.0% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of RMD?
- As of today, RMD TTM EBITDA is $2.18B
- What is RMD TTM EBITDA most recent change?
- RMD TTM EBITDA was up +0.77% on September 30, 2026
- What is 1-year change in RMD TTM EBITDA?
- RMD TTM EBITDA is up +9.07% year-over-year
- How far is RMD TTM EBITDA from its all-time high?
- RMD TTM EBITDA is currently -0.20% below its historical high of $2.19B set on March 31, 2026
- How does RMD TTM EBITDA rank versus sector peers?
- RMD TTM EBITDA is higher than 95.16% of companies in Healthcare sector
- When is RMD next earnings release?
- The next earnings release for RMD is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- RMD Official Website www.resmed.co.in
- RMD Profile on Yahoo Finance finance.yahoo.com/quote/RMD
- RMD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rmd
